GCP
BMY icon

Garda Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Garda Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,393
Closed -$859K – 352
2023
Q1 		$859K Buy
+12,393
New +$874K 0.04% 251

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Garda Capital Partners's BMY Position: Q2 2023 in Review

Garda Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 12,393 shares — an estimated $859K sold.

Garda Capital Partners first reported a position in BMY in Q1 2023 and held it in 1 quarter. The position peaked at $859K in Q1 2023. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Garda Capital Partners reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Garda Capital Partners sold 12,393 Bristol-Myers Squibb shares in Q2 2023, an estimated $859K.
  • Garda Capital Partners first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 1 quarter.
  • Garda Capital Partners's Bristol-Myers Squibb position peaked at $859K in Q1 2023.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Garda Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.